GloPID-R Funders Living Roadmap for Clinical Trial Coordination

Read more
GLOPID-R

Institute of Health Carlos III – Ministry of Science & Innovation – Spain

Scientific advances for the prevention, control, diagnosis and treatment of COVID-19 will greatly determine the health and socio-economic effects and impacts of the epidemic.

The ‘Special Spanish Research Programme on COVID-19’ will support specific new and running projects and programmes addressing this outbreak.

Scope

  • Rapid diagnostic techniques of SARS-CoV-2
  • Clinical-biological-molecular characterization of COVID-19
  • Development of innovative therapies, disinfectants and new antiviral molecules
  • Characterization of SARS-CoV-2
  • Vaccine development, efficacy and applicability
  • Epidemiological surveillance and molecular epidemiology: mortality and morbidity incidence
  • Environmental and social factors for its spread
  • Socio-economic impact
  • Artificial intelligence and massive analysis of integrated data oriented towards epidemiological control of COVID-19.

Read the full request for proposal (in English)
Read the full request for proposal (in Spanish)

  • Call budget: €24M
  • Call opens: March 19, 2020
  • Application deadline: No current deadline
EU Flag

The GloPID-R Secretariat is a project which receives funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 874667.